Source: Nasdaq

Acumen: Acumen Pharmaceuticals, Inc. Full Year Loss Rises

(RTTNews) - Acumen Pharmaceuticals, Inc. (ABOS) released Loss for its full year of -$102.33 million

Read full article »
Acumen's Competitors | Acumen's News | Acumen's Financials
Stay up-to-date with the latest news on Acumen
Annual Revenue
$100K-5.0M
Employees
25-100
Daniel J O'Connell's photo - President & CEO of Acumen

President & CEO

Daniel J O'Connell

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on Acumen